Standard BioTools Inc.
LAB
$1.05
-$0.02-1.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -138.89M | -124.59M | -118.65M | -89.97M | -74.66M |
| Total Depreciation and Amortization | 16.86M | 16.81M | 20.03M | 16.46M | 15.18M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | -3.09M | 256.00K | 0.00 |
| Total Other Non-Cash Items | 7.77M | 4.10M | 3.07M | 813.00K | 18.16M |
| Change in Net Operating Assets | -29.20M | -39.78M | -28.36M | -24.83M | -1.97M |
| Cash from Operations | -143.45M | -143.46M | -127.00M | -97.28M | -43.29M |
| Capital Expenditure | -8.36M | -5.05M | -3.70M | -2.60M | -2.83M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 278.65M | 280.03M | 280.03M | 280.03M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.88M | 49.35M | 28.96M | 17.73M | 23.07M |
| Cash from Investing | 363.17M | 324.33M | 305.29M | 295.16M | 20.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -63.19M | -9.44M | -10.28M | -10.28M | -2.08M |
| Issuance of Common Stock | 2.07M | 1.97M | 1.98M | 899.00K | 827.00K |
| Repurchase of Common Stock | -40.95M | -41.08M | -41.42M | -14.06M | -5.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -545.00K | -545.00K | -545.00K | -545.00K | -- |
| Cash from Financing | -102.62M | -49.10M | -50.26M | -23.98M | -6.81M |
| Foreign Exchange rate Adjustments | -785.00K | -288.00K | -27.00K | -10.00K | 34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.32M | 131.49M | 128.00M | 173.89M | -29.83M |
